Fiche société
Profound Medical Inc.
Traitements, essais et publications liés.
Traitements5programmes
Essais2liés
Publications0liées
SourceDBlocale
Traitements
5| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| MR-Guided Transurethral US Ablation of Prostate TissueThis study is to evaluate that the magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy system is safe and feasible to ablate prostate tissue in men with localized prostate cancer. | Cancer | Non applicable | À vérifier | United States, Canada, Germany | À vérifier |
| Radical ProstatectomyMen with localized, intermediate risk prostate cancer will be randomized to undergo either radical prostatectomy or the TULSA procedure, with a follow-up of 10 years in this multi-centered randomized control trial. This study will determine whether the TULSA procedure is as effective and more safe compared to radical prostatectomy. | Cancer | Non applicable | À vérifier | United States, Canada, Finland | À vérifier |
| TULSA ProcedureMen with localized, intermediate risk prostate cancer will be randomized to undergo either radical prostatectomy or the TULSA procedure, with a follow-up of 10 years in this multi-centered randomized control trial. This study will determine whether the TULSA procedure is as effective and more safe compared to radical prostatectomy. | Cancer | Non applicable | À vérifier | United States, Canada, Finland | À vérifier |
| MR-Guided Transurethral US Ablation of Prostate TissueThis study is to evaluate that the magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy system is safe and feasible to ablate prostate tissue in men with localized prostate cancer. | Cancer | Non applicable | À vérifier | United States, Canada, Germany | À vérifier |
| Radical ProstatectomyMen with localized, intermediate risk prostate cancer will be randomized to undergo either radical prostatectomy or the TULSA procedure, with a follow-up of 10 years in this multi-centered randomized control trial. This study will determine whether the TULSA procedure is as effective and more safe compared to radical prostatectomy. | Cancer | Non applicable | À vérifier | United States, Canada, Finland | À vérifier |
Essais cliniques
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Radical Prostatectomy | Cancer | Non applicable | NCT05027477 | CAPTAIN — A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer | ACTIVE_NOT_RECRUITING |
| MR-Guided Transurethral US Ablation of Prostate Tissue | Cancer | Non applicable | NCT01686958 | Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer | COMPLETED |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||